Jian Qin (Michael) Yu, MD, FRCPC

I joined the staff at Fox Chase Cancer Center in 2005 as Chief of Nuclear Medicine and PET service.

I chose the field of Nuclear Medicine and PET because I am interested in functional and molecular imaging. The nuclear medicine studies provide sensitive and early detection for many disease processes. It's gratifying when I can help cancer patients by staging (determining the extent of) and restaging their tumor correctly, monitoring their response to therapy and checking for recurrence (the cancer coming back).

I choose to practice at Fox Chase because of its emphasis on a team approach to patient care and for the opportunity to do research. I work closely with other cancer experts to provide the best care possible for our patients.

My clinical interests focus on the use of positron emission tomography (PET) for diagnostic and molecular imaging. I also take care of patients who receive radiotargeted and radioimmune therapy.

My research interests involve PET and targeted therapy in oncology. I am involved in several imaging trials with cooperative groups, such as the Radiation Therapy Oncology Group (RTOG), Gynecologic Oncology Group (GOG) and American College of Radiology Imaging Network (ACRIN). I also participate in several industry-sponsored national and international studies for drug development and evaluation.

In addition to my clinical and research duties at Fox Chase, I am an active member of the Center's Institutional Review Board (IRB) and the Radiation Safety Committee.